The role of CRF2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia

NeuroReport

Volumn 9, Issue 7, 1998, Pages 1601-1606

  Smagin, Gennady N ^a   Howell, Leigh A ^a   Ryan, Donna H ^a   De Souza, Errol B ^b   Harris, Ruth B S ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b NEUROCRINE BIOSCIENCES INC   (United States)

Author keywords

Antisense oligonucleotides; Corticosterone; HPA axis; Selective antagonist

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; MESSENGER RNA; OLIGONUCLEOTIDE; RECEPTOR SUBTYPE; UROCORTIN; CRF RECEPTOR TYPE 2; NUCLEOTIDE; OLIGODEOXYRIBONUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; CONTROLLED STUDY; FOOD INTAKE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; ANIMAL; BIOSYNTHESIS; BRAIN VENTRICLE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HUMAN; INFUSION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANOREXIA; CEREBRAL VENTRICLES; CORTICOTROPIN-RELEASING HORMONE; HUMANS; INFUSIONS, PARENTERAL; INJECTIONS, INTRAVENTRICULAR; MALE; OLIGODEOXYRIBONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; THIONUCLEOTIDES;

EID: 0032507504     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199805110-00063     Document Type: Article

References (25)

1. Koob GF. Behavioral responses to stress. Focus on corticotropin-releasing factor. In: Brown MR, Koob GF and Rivier C, eds. Stress. Neurobiology and Neuroendocrinology. New York: Marcel Dekker, Inc. 1991: 255-271.
2. Dunn AJ and Berridge CW. Brain Res Brain Res Rev 15, 71-100 (1990).
3. Richard D. Ann NY Acad Sci 697, 155-172 (1993).
4. Perrin MH, Donaldson CJ, Chen R et al. Endocrinology 133, 3058-3061 (1993).
5. Grigoriadis DE, Lovenberg TW, Chalmers DT et al. Ann NY Acad Sci 780, 60-80 (1996).
6. Lovenberg TW, Chalmers DT, Liu C and De Souza EB. Endocrinology 139, 4139-4142 (1995).
7. Chalmers DT, Lovenberg TW and De Souza EB. J Neurosci 15, 6340-6350 (1995).
8. Krahn DD, Gosnell BA, Grace M and Levine AS. Brain Res Bull 17, 285-289 (1986).
9. Negri L, Noviello L and Noviello V. Peptides 6, 53-57 (1985).
10. Vaughan J, Donaldson C, Bittencourt J et al. Nature 378, 287-292 (1995).
11. Spina M, Merio-Pich E, Chan RK. Science 273, 1561-1564 (1996).
12. Moreau JL, Kilpatrick G and Jenck F. NeuroReport 8, 1697-1701 (1997).
13. De Souza EB. Psychoneuroendocrinology 20, 789-819 (1995).
14. Schulz DW, Mansbach RS, Sprouse J et al. Proc Natl Acad Sci USA 93, 10477-10482 (1996).
15. Fitzgerald LW, Gilligan P, Culp S et al. Soc Neurosci Abstr 22, 1546 (1996).
16. Webster EL, Lewis DB, Torpy DJ et al. Endocrinology 137, 5747-5750 (1996).
17. Chen C, Dagnino R, De Souza EB et al. J Med Chem 39, 4358-4360 (1996).
18. McCarthy MM, Kleopoulos SP, Mobbs CV and Pfaff DW. Neuroendocrinology 59, 432-440 (1994).
19. Owens MJ, Mulchahey JJ, Kasckow JW et al. J Neurochem 64, 2358-2361 (1995).
20. Skutella T, Stohr T, Probst JC et al. Horm Metab Res 26, 460-464 (1994).
21. Schobitz B, Pezeshki G, Probst JC et al. Eur J Pharmacol 331, 97-107 (1997).
22. Heinrichs SC and Koob GF. Psychopharmacology 109, 177-184 (1992).
23. Heinrichs SC, Britton KT and Koob GF. Pharmacol Biochem Behav 40, 717-721 (1991).
24. Behan DP, Khongslay O, Ling N and De Souza EB. Brain Res 725, 263-267 (1996).
25. Lorang MT, Chen C, McCarthy JR et al. Soc Neurosci Abstr 23, 1764 (1997).